BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25294114)

  • 1. Antibody screening in multitransfused patients: a prerequisite before each transfusion.
    Lamba DS; Mittal K; Sood T; Bedi RK; Kaur P; Kaur G
    Transfus Apher Sci; 2014 Oct; 51(2):132-3. PubMed ID: 25294114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cells alloimmunization and autoimmunization among transfusion-dependent beta-thalassemia patients in Alexandria province, Egypt.
    Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
    Transfus Apher Sci; 2015 Aug; 53(1):52-7. PubMed ID: 25817267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
    Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
    Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red Cell Alloimmunization In Multitransfused Thalassaemia Major Patients.
    Moeen S; Farooq N; Irshad R; Ashfaq M; Farooq U; Idris M
    J Ayub Med Coll Abbottabad; 2018; 30(1):81-84. PubMed ID: 29504337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors.
    El Kababi S; Benajiba M; El Khalfi B; Hachim J; Soukri A
    Transfus Clin Biol; 2019 Nov; 26(4):240-248. PubMed ID: 31279519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloimmunization to red cells in thalassemics: emerging problem and future strategies.
    Gupta R; Singh DK; Singh B; Rusia U
    Transfus Apher Sci; 2011 Oct; 45(2):167-70. PubMed ID: 21856231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
    Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
    Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBC alloimmunization and double alloantibodies in thalassemic patients.
    Azarkeivan A; Ahmadi MH; Zolfaghari S; Shaiegan M; Ferdowsi S; Rezaei N; Lotfi P
    Hematology; 2015 May; 20(4):223-7. PubMed ID: 25130935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunization against human platelet antigen 2 (HPA2) in a series of multi-transfused beta-thalassemia patients.
    Tazzari PL; Ricci F; Tassi C; Bontadini A; Fruet F; Conte R
    Haematologica; 1998 Aug; 83(8):765-6. PubMed ID: 9793272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.
    Cheng CK; Lee CK; Lin CK
    Transfusion; 2012 Oct; 52(10):2220-4. PubMed ID: 22339270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
    Lo SC; Chang JS; Lin SW; Lin DT
    Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients.
    Saied DA; Kaddah AM; Badr Eldin RM; Mohaseb SS
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):409-14. PubMed ID: 21792035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.
    Karimi M; Nikrooz P; Kashef S; Jamalian N; Davatolhagh Z
    Int J Lab Hematol; 2007 Oct; 29(5):321-6. PubMed ID: 17824911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
    el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
    Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
    Hindawi S; Badawi M; Elfayoumi R; Elgemmezi T; Al Hassani A; Raml M; Alamoudi S; Gholam K
    Transfusion; 2020 Feb; 60 Suppl 1():S15-S21. PubMed ID: 32134130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leucocyte antigen alloimmunisation in repeatedly transfused thalassemic Egyptian children and its relation to febrile non-haemolytic transfusion reactions.
    Mourad Z; Hassab H; Younan D; Abdo A
    Transfus Med; 2015 Dec; 25(6):380-4. PubMed ID: 26578338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody screening in repeatedly transfused patients.
    Hassab AH; Sorour AF; Ahmed MI; Salama MA; Aly AK
    Egypt J Immunol; 2008; 15(2):1-14. PubMed ID: 20306683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.